AMYT Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (4 Jun 2024 @ 16:00):

Stats
Today's Volume	2.38M
Average Volume	0
Market Cap	0.00
EPS	$-0.320 ( Q3 \| 2022-09-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	39.73 (Sector) 42.63 (Industry) 0
ATR14	$0.0580 (0.39%)

ACOR -24.02%

ACRX 7.50%

ADMP 0.85%

ADMS 0.00%

AGRX 0.71%

AKAN -2.16%

ALIM -0.72%

AMPH -3.73%

AMYT 0.00%

ANIP -0.38%

AQST -5.77%

ASRT -4.03%

ATNX 0.00%

AVDL 0.43%

AYTU -2.06%

BFRI -0.67%

BGXX 8.76%

CLVR -1.52%

COLL 1.30%

CPIX -3.27%

CRDL -0.99%

CRON -1.29%

CYTH -5.51%

DCPH 0.00%

DERM -4.79%

DRRX 1.55%

DVAX -0.62%

EGRX -1.25%

EMBC -2.80%

EMBCV -9.33%

EOLS 2.12%

ESPR 5.41%

EVOK -10.81%

FLGC -2.94%

FLXN 0.00%

GHSI -2.08%

HCM 2.57%

HROW 0.77%

HUGE -14.49%

IMCC -3.43%

INCR 1.00%

IRWD 0.00%

ITCI -0.73%

IXHL 0.34%

JUPW 11.76%

KALA -2.82%

KIN 0.11%

KMDA -3.40%

LNTH -0.36%

NBIX 1.77%

NEPT 0.00%

NLTX 1.45%

OGI 0.00%

OPTN 0.96%

ORGO -3.57%

PAHC 1.61%

PCRX -0.52%

PETQ 3.67%

PLXP 0.00%

PPD 0.00%

PROC 3.16%

PRPH -2.87%

PTPI -5.66%

RDHL -2.00%

RDUS 0.13%

REPH -0.48%

RGC -5.03%

RMTI -5.11%

SCTL 0.92%

SCYX -2.50%

SIGA -0.53%

SISI -14.23%

SNDL 1.05%

SNOA 8.44%

SSIC -2.37%

SUPN -0.75%

SXTC -2.79%

THTX -1.41%

TKNO -11.68%

TLGT -13.85%

TLRY 1.20%

TXMD 6.21%

TYHT -3.90%

UPC 2.08%

VTRS -0.38%

ZYNE 2.36%

Volume Correlation

Long: 0.18 (neutral)

Short: 0.00 (neutral)

Signal:(69.184) Neutral

Amryt Pharma plc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Amryt Pharma plc Correlation - Currency/Commodity

-0.27
( neutral )

-0.02
( neutral )

-0.52
( weak negative )

0.25
( neutral )

0.86
( strong )

0.35
( neutral )

Amryt Pharma plc Financials

Annual	2021
Revenue:	$222.54M
Gross Profit:	$116.42M (52.32 %)
EPS:	$-0.573

FY	2021
Revenue:	$222.54M
Gross Profit:	$116.42M (52.32 %)
EPS:	$-0.573

FY	2020
Revenue:	$182.61M
Gross Profit:	$63.58M (34.82 %)
EPS:	$-3.30

FY	2019
Revenue:	$58.12M
Gross Profit:	$16.12M (27.74 %)
EPS:	$-4.30

Financial Reports:

No articles found.

Amryt Pharma plc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Amryt Pharma plc

Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy; oral octreotide, a long-term maintenance therapy in acromegaly patients; and lomitapide, an adjunct to a low-fat diet and other lipid-lowering medicinal products for adults with the Homozygous familial Hypercholesteraemia. Its development candidates include Oleogel-S10 for the cutaneous manifestations of Junctional and Dystrophic Epidermolysis Bullosa (EB), a rare and distressing genetic skin disorder affecting young children and adults; and AP103, a pre-clinical gene therapy for patients with dystrophic EB. The company sells its products in the Americas, Europe, and the Middle East. Amryt Pharma plc was founded in 2015 and is headquartered in Dublin, Ireland.